THE LARGEST COLLECTION OF JOBS ON EARTH
Supports PDF, DOC, DOCX, TXT, XLS, WPD, HTM, HTML files up to 5 MB
... company committed to developing innovative antibody-based therapies for the treatment of ... platform enables the design and engineering of precision antibody-based product candidates that specifically bind ... Massachusetts.rnrnSummaryrnrnThe Scientist..
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables the ..
... a robust pipeline of innovative antibody-based therapies for patients with unmet ... laboratory enables the design and engineering of precision antibody-based product candidates that specifically bind ... and technologies..
Associate Director, Talent Acquisition and New Employee ... a robust pipeline of innovative antibody-based therapies for patients with unmet ... laboratory enables the design and engineering of precision antibody-based product..
... platform enables the design and engineering of precision antibody or protein-based drug candidates that ... to site).rnrnSummaryrnrnWith guidance from the Director, CMC, Pharmaceutical Sciences and Technology, ... group with..
... a robust pipeline of innovative antibody-based therapies for patients with unmet ... laboratory enables the design and engineering of precision antibody-based product candidates that specifically bind ... of regulatory..
... a robust pipeline of innovative antibody-based therapies for patients with unmet ... laboratory enables the design and engineering of precision antibody-based product candidates that specifically bind ... global company.rnrn..
... platform enables the design and engineering of precision antibody or protein-based drug candidates to ... through commercialization. Reporting to the Director, CMC, the scientist is also ... capabilities. rnrnrnRequirements..
Visterra is a clinical stage biotechnology company committed to developing innovative biologic therapies (monoclonal antibodies and therapeutic muteins) for the treatment of kidney diseases, with an immuno-nephrology focus in drug development. ..
... company committed to developing innovative antibody-based therapies for the treatment of ... platform enables the design and engineering of precision antibody-based product candidates that specifically bind ... located in..
